CME icon

CME Group

262.54 USD
+0.30
0.11%
At close Apr 2, 4:00 PM EDT
After hours
260.00
-2.54
0.97%
1 day
0.11%
5 days
-0.28%
1 month
2.20%
3 months
12.81%
6 months
17.43%
Year to date
12.81%
1 year
22.23%
5 years
55.75%
10 years
182.57%
 

About: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Employees: 3,760

0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

159% more first-time investments, than exits

New positions opened: 189 | Existing positions closed: 73

53% more call options, than puts

Call options by funds: $492M | Put options by funds: $322M

41% more funds holding in top 10

Funds holding in top 10: 37 [Q3] → 52 (+15) [Q4]

20% more repeat investments, than reductions

Existing positions increased: 580 | Existing positions reduced: 484

6% more funds holding

Funds holding: 1,369 [Q3] → 1,455 (+86) [Q4]

6% more capital invested

Capital invested by funds: $70.5B [Q3] → $74.6B (+$4.11B) [Q4]

0.47% less ownership

Funds ownership: 88.78% [Q3] → 88.31% (-0.47%) [Q4]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$212
19%
downside
Avg. target
$255
3%
downside
High target
$287
9%
upside

10 analyst ratings

positive
30%
neutral
50%
negative
20%
B of A Securities
Craig Siegenthaler
63% 1-year accuracy
17 / 27 met price target
17%downside
$219
Underperform
Maintained
2 Apr 2025
Raymond James
Patrick O'Shaughnessy
67% 1-year accuracy
12 / 18 met price target
9%upside
$287
Outperform
Upgraded
10 Mar 2025
Morgan Stanley
Mike Cyprys
43% 1-year accuracy
3 / 7 met price target
0%upside
$263
Equal-Weight
Maintained
19 Feb 2025
Keefe, Bruyette & Woods
Kyle Voigt
71% 1-year accuracy
22 / 31 met price target
2%downside
$257
Market Perform
Maintained
14 Feb 2025
RBC Capital
Ashish Sabadra
57% 1-year accuracy
29 / 51 met price target
2%upside
$269
Sector Perform
Maintained
13 Feb 2025

Financial journalist opinion

Based on 30 articles about CME published over the past 30 days

Positive
The Motley Fool
8 hours ago
CME Group: A Fortress in Financial Infrastructure
Explore the exciting world of CME Group (CME 0.17%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
CME Group: A Fortress in Financial Infrastructure
Neutral
PRNewsWire
17 hours ago
CME Group to Launch Spot-Quoted Futures, Providing Innovative New Trading Opportunities for Retail Investors
Smaller-sized, longer-dated contracts will create new trading opportunities across the leading cryptocurrency and equity index markets CHICAGO , April 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch Spot-Quoted futures on June 30, pending regulatory review. Spot-Quoted futures will allow investors to trade futures positions in spot-market terms (i.e.
CME Group to Launch Spot-Quoted Futures, Providing Innovative New Trading Opportunities for Retail Investors
Neutral
PRNewsWire
19 hours ago
CME Group Sets New, All-Time Quarterly ADV Record of 29.8 Million Contracts, Driven by Growth Across All Asset Classes
Second-Highest March ADV of 30.8 million contracts, up 27% year-over-year Record quarterly ADV for interest rate, equity index, agricultural, foreign exchange and cryptocurrency products Record quarterly ADV in U.S. Treasury and Henry Hub Natural Gas complexes Record quarterly international ADV of 8.8 million contracts CHICAGO , April 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its Q1 and March 2025 market statistics, with average daily volume (ADV) reaching a new, all-time quarterly record of 29.8 million contracts and the second-highest March ADV on record with 30.8 million contracts. In Q1, the company's ADV grew 13% year-over-year, with record volume in interest rate, equity index, agricultural, foreign exchange and cryptocurrency products.
CME Group Sets New, All-Time Quarterly ADV Record of 29.8 Million Contracts, Driven by Growth Across All Asset Classes
Neutral
Seeking Alpha
3 days ago
Comprehensive Q1 Review Of My Stock Picks + Ratings Updates
Although there is one day left in Q1, I'm pleased to present a detailed review of my Q1 stock picks, along with updated commentary and ratings. Today's report begins with an unconventional review of Apple, which I plan to drop coverage on. This report contains new coverage of 38 stocks that I've previously written about here at Seeking Alpha.
Comprehensive Q1 Review Of My Stock Picks + Ratings Updates
Neutral
Seeking Alpha
5 days ago
CME Group: A High-Yield Tollbooth On Global Financial Volatility
CME Group is a high-margin, capital-light business benefiting from network effects, offering strong cash flow and a competitive dividend yield, making it attractive for income investors. CME's wide moat is reinforced by its dominance in U.S. interest rate futures and exclusive product licenses, ensuring durable competitive advantages. The company's scalable business model and consistent dividend policy, including a variable annual dividend, provide potential for double-digit annual returns.
CME Group: A High-Yield Tollbooth On Global Financial Volatility
Positive
Zacks Investment Research
6 days ago
Are You Looking for a Top Momentum Pick? Why CME Group (CME) is a Great Choice
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why CME Group (CME) is a Great Choice
Neutral
Zacks Investment Research
6 days ago
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
Here we discuss five non-tech stocks that have provided double-digit returns year to date, defying the negative trends of U.S. stock markets. These are TPR, WEC, CNP, CME and CEH.
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1
Positive
Seeking Alpha
6 days ago
CME Group At A New All-Time High - Valuation Concerns Justified?
CME shares have delivered market-beating returns over the past two years, prompting the question of whether it's time to lock in profits. In this update, I discuss whether the rally appears sustainable against the backdrop of the 2024 results published in mid-February. The analysis focuses on average contract volumes and rates, signs of potential underinvestment given the surprisingly strong free cash flow, and includes an update on debt and leverage.
CME Group At A New All-Time High - Valuation Concerns Justified?
Positive
Zacks Investment Research
1 week ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
CNBC Television
1 week ago
Josh Brown's "Best Stocks in the Market" list update
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to give us an update on why he's getting rid of one of the stocks on the list.
Josh Brown's "Best Stocks in the Market" list update
Charts implemented using Lightweight Charts™